.A.; Leedm.an, P.J. The 3′-untranslated region of p21WAF

.A.; Leedm.an, P.J. The 3′-untranslated region of p21WAF1 mRNA can be a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J. Biol. Chem. 2003, 278, 2937946. 134. Leandersson, K.; Riesbeck, K.; Andersson, T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res. 2006, 34, 3988999. 135. Yoo, P.S.; Mulkeen, A.L.; Cha, C.H. Post-transcriptional regulation of vascular endothelial growth element. Implications for tumor angiogenesis. Planet J. Gastroenterol. 2006, 12, 4937942. 136. Ido, K.; Nakagawa, T.; Sakuma, T.; Takeuchi, H.; Sato, K.; Kubota, T. Expression of vascular endothelial growth factor-A and mRNA stability issue HuR in human astrocytic tumors. Neuropathology 2008, 28, 60411. 137. Sakuma, T.; Nakagawa, T.; Ido, K.; Takeuchi, H.; Sato, K.; Kubota, T. Expression of vascular endothelial development factor-A and mRNA stability aspect HuR in human meningiomas. J. Neurooncol. 2008, 88, 14355. 138. Niesporek, S.; Kristiansen, G.; Thoma, A.; Weichert, W.; Noske, A.; Buckendahl, A.C.; Jung, K.; Stephan, C.; Dietel, M.; Denkert, C. Expression of your ELAV-like protein HuR in human prostate carcinoma is definitely an indicator of illness relapse and linked to COX-2 expression. Int. J. Oncol. 2008, 32, 34147.Int. J. Mol. Sci. 2013,139. Dixon, D.A.; Tolley, N.D.; King, P.H.; Nabors, L.B.; McIntyre, T.M.; Zimmerman, G.A.; Prescott, S.M. Altered expression in the mRNA stability issue HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 2001, 108, 1657665. 140. Erkinheimo, T.L.; Lassus, H.; Sivula, A.; Sengupta, S.; Furneaux, H.; Hla, T.; Haglund, C.; Butzow, R.; Ristimaki, A. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase two expression in serous ovarian carcinoma.Rilotumumab Cancer Res.GL0388 2003, 63, 7591594.PMID:24282960 141. Yoo, P.S.; Sullivan, C.A.; Kiang, S.; Gao, W.; Uchio, E.M.; Chung, G.G.; Cha, C.H. Tissue microarray analysis of 560 individuals with colorectal adenocarcinoma. high expression of HuR predicts poor survival. Ann. Surg. Oncol. 2009, 16, 20007. 142. Richards, N.G.; Rittenhouse, D.W.; Freydin, B.; Cozzitorto, J.A.; Grenda, D.; Rui, H.; Gonye, G.; Kennedy, E.P.; Yeo, C.J.; Brody, J.R.; et al. HuR status is really a strong marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma sufferers. Ann. Surg. 2010, 252, 49905. 143. Kurosu, T.; Ohga, N.; Hida, Y.; Maishi, N.; Akiyama, K.; Kakuguchi, W.; Kuroshima, T.; Kondo, M.; Akino, T.; Totsuka, Y.; et al. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br. J. Cancer 2011, 104, 81929. 144. Gubin, M.M.; Calaluce, R.; Davis, J.W.; Magee, J.D.; Strouse, C.S.; Shaw, D.P.; Ma, L.; Brown, A.; Hoffman, T.; Rold, T.L.; et al. Overexpression of the RNA binding protein HuR impairs tumor development in triple negative breast cancer connected with deficient angiogenesis. Cell Cycle 2010, 9, 3337346. 145. Calaluce, R.; Gubin, M.M.; Davis, J.W.; Magee, J.D.; Chen, J.; Kuwano, Y.; Gorospe, M.; Atasoy, U. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor adverse and estrogen receptor good breast cancer. BMC Cancer 2010, ten, 126. 146. Ale-Agha, N.; Galban, S.; Sobieroy, C.; Abdelmohsen, K.; Gorospe, M.; Sies, H.; Klotz, L.O. HuR regulates gap junctional intercellular communication by controlling beta-catenin.